Clinical Trials Browser

Phase 2 × Osteosarcoma × pembrolizumab × Clear all

NCT02406781 2025-12-10

PEMBROSARC

Phase 2 Completed

129 enrolled 17 charts

Leiomyosarcoma, Sarcoma, Osteosarcoma

NCT03013127 2020-10-14

PROMO

Phase 2 Terminated

Osteosarcoma